metharbital (gemonil) Report issue

Small molecule Approved FDA
ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem

Active Ingredient History

NOW
  • Now
Methbarbital is a barbiturate anticonvulsant, discovered by Merck in 1905. It was introduced to market for treatment of epolepsy by Abbott in 1952, and discontinued in 1990.   NCATS

Chemistry

More Chemistry

Pharmacology

Alternative names

2,4,6(1h,3h,5h)-pyrimidinetrione, 5,5-diethyl-1-methyl- | endiemal | gemonil | metabarbital | metarbital | methabarbitone | metharbital | metharbitalum | metharbitone | methobarbitone | methylbarbital | n-methylbarbital

Organizations (2)

Research & Development (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (2)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (1)

Approved Indications (1)


 

Epilepsy

Experimental Indications - Clinical Trial Phases 1-4 (0)

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue